수상
Methodology Workshop 2022, 우수연구자상
KSMO 2020, Poster Award
1. Park K, Kim JY, Park I, Shin SH, Lee HJ, Lee JL. Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice. Yonsei Med J. 2023 Feb;64(2):86-93. doi: 10.3349/ymj.2022.0244. (제1저자)
2. Park JH, Park I, Kim IH, Hur JY, Hwang I, Kim C, Kim HJ, Maeng CH, Park K, Lee MY, Lee HJ, Jung JY, Keam B, Park SH, Lee JL. Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure. Curr Probl Cancer. 2022 Jun;46(3):100848. doi: 10.1016/j.currproblcancer.2022.100848. Epub 2022 Mar 8.
3. Kim JJ, Park K, Han YR, Kim SH, Oh SB, Oh SY, Hong YJ, Yun MS. Verification of performance of a direct fluorescent assay for cell-free DNA quantification, stability according to pre-analytical storage conditions, and the effect of freeze-thawing. Biomed Rep. 2021 Aug;15(2):68. doi: 10.3892/br.2021.1444. Epub 2021 Jun 15. (교신저자)
4. Kim SH, Suh SY, Yoon SJ, Park J, Kim YJ, Kang B, Park Y, Kwon JH, Park K, Kim JY, Choi H, Ahn HY, Hamano J, Hui D. "The surprise questions" using variable time frames in hospitalized patients with advanced cancer. Palliat Support Care. 2022 Apr;20(2):221-225. doi: 10.1017/S1478951521000766.
5. 2020 Korean guidelines for the management of metastatic prostate cancer. Kim IH, Shin SJ, Kang BW, Kang J, Kim D, Kim M, Kim JY, Kim CK, Kim HJ, Maeng CH, Park K, Park I, Bae WK, Sohn BS, Lee MY, Lee JL, Lee J, Lim ST, Lim JH, Chang H, Jung JY, Choi YJ, Kim YS, Cho J, Joung JY, Park SH, Lee HJ. Korean J Intern Med. 2021 May;36(3):491-514. doi: 10.3904/kjim.2020.213. Epub 2021 Feb 10.
6. Oh SB, Park K, Kim JJ, Oh SY, Jung KS, Park BS, Son GM, Kim HS, Kim DH, Jung HJ, Lee SS. Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments. Medicine (Baltimore). 2021 Jan 15;100(2):e24156. (교신저자)
7. Park EJ, Park K, Kim JJ, Oh SB, Jung KS, Oh SY, Hong YJ, Kim JH, Jang JY, Jeon UB. Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study. Cancer Res Treat. 2021 Jul;53(3):881-888. doi: 10.4143/crt.2020.1008. Epub 2020 Dec 22. (교신저자)
8. Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients. Seo JY, Ahn JY, Keam B, Kim M, Yoon S, Lee JL, Park K, Park I.
Ann Lab Med. 2021 Mar 1;41(2):207-213. doi: 10.3343/alm.2021.41.2.207.
9. Lee HY, Hong JH, Byun JH, Kim HJ, Baek SK, Kim JY, Kim KH, Yun J, Kim JA, Park K, Lee HJ, Lee JL, Won YW, Kim IH, Bae WK, Park KH, Sun DS, Lee S, Lee MY, Lee GJ, Hong SH, Jung YH, An HJ. Clinical Characteristics of Clear Cell Ovarian Cancer: A Retrospective Multicenter Experience of 308 Patients in South Korea. Cancer Res Treat. 2019 Jul 12. doi: 10.4143/crt.2019.292.
10. Park K, Baek Y, Lee JL. Random Allocated Study of Wrapping Oblate for Prevention of Everolimus-associated Stomatitis in Patients With Metastatic Renal Cell Carcinoma. Anticancer Res. 2019 Jul;39(7):3937-3944 (제1저자)
11. ParK EJ, Lim YJ, Kim JJ, Oh SB, Oh SY, Park K. Feasibility of Early Application of an Advance Directive at the Time of First-Line Palliative Chemotherapy in Patients With Incurable Cancer: A Prospective Study. Am J Hosp Palliat Care. 2019 Oct;36(10):893-899. (교신저자)
진료가능
클리닉센터
휴진-진료없음
정원초과
클리닉 정원초과
